BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1830 related articles for article (PubMed ID: 25108580)

  • 1. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
    Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
    Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous Ablation Versus Robotic Partial Nephrectomy in the Treatment of cT1b Renal Tumors: Oncologic and Functional Outcomes of a Propensity Score-weighted Analysis.
    Rembeyo G; Correas JM; Jantzen R; Audenet F; Dariane C; Delavaud C; Mejean A; Timsit MO
    Clin Genitourin Cancer; 2020 Apr; 18(2):138-147. PubMed ID: 31982346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.
    Stern JM; Svatek R; Park S; Hermann M; Lotan Y; Sagalowsky AI; Cadeddu JA
    BJU Int; 2007 Aug; 100(2):287-90. PubMed ID: 17617136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes.
    Moynagh MR; Schmit GD; Thompson RH; Boorjian SA; Woodrum DA; Curry TB; Atwell TD
    J Vasc Interv Radiol; 2015 Jun; 26(6):800-6. PubMed ID: 25840835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
    Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
    J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
    Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
    Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Growth Kinetics and Oncologic Outcomes of Patients Undergoing Active Surveillance for Residual Renal Tumor following Percutaneous Thermal Ablation.
    Chen JX; Maass D; Guzzo TJ; Bruce Malkowicz S; Wein AJ; Soulen MC; Clark TWI; Nadolski GJ; William Stavropoulos S
    J Vasc Interv Radiol; 2016 Sep; 27(9):1397-1406. PubMed ID: 27234485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: Comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype.
    Liu N; Huang D; Cheng X; Chong Y; Wang W; Gan W; Guo H
    Urol Oncol; 2017 Aug; 35(8):530.e1-530.e6. PubMed ID: 28408296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes After Cryoablation Versus Partial Nephrectomy for Sporadic Renal Tumors in a Solitary Kidney: A Propensity Score Analysis.
    Bhindi B; Mason RJ; Haddad MM; Boorjian SA; Leibovich BC; Atwell TD; Weisbrod AJ; Schmit GD; Thompson RH
    Eur Urol; 2018 Feb; 73(2):254-259. PubMed ID: 28967553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland.
    Weight CJ; Kim SP; Lohse CM; Cheville JC; Thompson RH; Boorjian SA; Leibovich BC
    Eur Urol; 2011 Sep; 60(3):458-64. PubMed ID: 21514718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermal ablation of small renal masses: intermediate outcomes from a Canadian center.
    Erdeljan P; Dhar M; Wignall G; Kozak R; Pautler SE
    Can J Urol; 2011 Oct; 18(5):5903-7. PubMed ID: 22018153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma.
    Gershman B; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2018 Dec; 74(6):825-832. PubMed ID: 30262341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience.
    Tanagho YS; Bhayani SB; Kim EH; Figenshau RS
    J Endourol; 2013 Dec; 27(12):1477-86. PubMed ID: 24283518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elective partial nephrectomy is equivalent to radical nephrectomy in patients with clinical T1 renal cell carcinoma: results of a retrospective, comparative, multi-institutional study.
    Antonelli A; Ficarra V; Bertini R; Carini M; Carmignani G; Corti S; Longo N; Martorana G; Minervini A; Mirone V; Novara G; Serni S; Simeone C; Simonato A; Siracusano S; Volpe A; Zattoni F; Cunico SC;
    BJU Int; 2012 Apr; 109(7):1013-8. PubMed ID: 21883829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting.
    Long JA; Bernhard JC; Bigot P; Lanchon C; Paparel P; Rioux-Leclercq N; Albiges L; Bodin T; Nouhaud FX; Boissier R; Gimel P; Méjean A; Masson-Lecomte A; Grenier N; Cornelis F; Grassano Y; Comat V; Le Clerc QC; Rigaud J; Salomon L; Descotes JL; Sengel C; Roupret M; Verhoest G; Ouzaid I; Arnoux V; Bensalah K;
    World J Urol; 2017 Apr; 35(4):649-656. PubMed ID: 27498139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 92.